MEDIKURA is creating the leading operating system for patient safety. Our process innovation helps pharma companies to capture, enrich, and analyze drug-related data provided by patients and doctors. We address the societal problem that more than 200.000 European citizens die from drug side-effects every year, whereas less than 1% of suspected cases are officially reported by patients and doctors. To improve drug safety, the new EU regulation ICH E2B(R3) came into effect in late 2017. As a result, pharma companies are subject to increasing cost and time pressure in side-effect monitoring. Our solution is to build the digital infrastructure for side-effect data – to improve patient safety, enable more targeted therapies and accelerate data-driven drug discovery. We streamline the process of capturing, enriching, and analyzing side-effect data through a cloud-based platform that connects pharma companies with patients and doctors. Our goal is to replace the decentralized, analogue patient safety process with a transparent, centralized, and digital system. In addition to the numerous advantages for patients and healthcare professionals, we offer a tree-fold value proposition to pharmaceutical companies. In terms of time savings, we reduce the timespan to close a side-effect case and report it to public authorities by up to 90%. In terms of money, we can save processing cost of more than 50% per side-effect case and reduce liability risk. In terms of data quality, we provide comprehensive information through a digital backchannel to patients, doctors and pharmacists that allows to enrich drug-related data and prepare it for subsequent analyses.
